🟢 Moleculin Biotech is trading 6.03% up in after-hours trading with no clear catalyst identified

Moleculin Biotech is trading 6.03% up at $0.69 after an after-hours rebound with no clear company-specific catalyst.

• It closed August 28, 2026, at $0.65 after a 5.63% regular-session decline.
• No announcement, earnings release, filing, or late-breaking catalyst dated August 28 explains the rebound.
• The latest company update was an August 27 Virtual Investor conference announcement.